ONCSM Stock Overview
Provides consumables, medical devices, diagnostic products, and protective equipment. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₺97.10 |
| 52 Week High | ₺268.00 |
| 52 Week Low | ₺90.60 |
| Beta | 0 |
| 11 Month Change | 2.32% |
| 3 Month Change | -50.48% |
| 1 Year Change | -40.54% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 404.42% |
Recent News & Updates
Recent updates
Shareholder Returns
| ONCSM | TR Medical Equipment | TR Market | |
|---|---|---|---|
| 7D | -0.9% | -1.3% | 1.8% |
| 1Y | -40.5% | -3.2% | 11.9% |
Return vs Industry: ONCSM underperformed the TR Medical Equipment industry which returned -3.2% over the past year.
Return vs Market: ONCSM underperformed the TR Market which returned 11.9% over the past year.
Price Volatility
| ONCSM volatility | |
|---|---|
| ONCSM Average Weekly Movement | 9.0% |
| Medical Equipment Industry Average Movement | 6.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in TR Market | 8.9% |
| 10% least volatile stocks in TR Market | 4.6% |
Stable Share Price: ONCSM's share price has been volatile over the past 3 months compared to the TR market.
Volatility Over Time: ONCSM's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of TR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 259 | Erol Celik | www.oncosem.com |
Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi provides consumables, medical devices, diagnostic products, and protective equipment. The company offers OncoCare Monolitik, an automated chemotherapy drug preparation device; OncoCare Plus, a chemotherapy drug guide; OncoWaste and M-Waste, a hazardous waste sealing system; OncoCare Set, a chemotherapy preparation and administration consumables; and Oncocare Infusion Pump. It also provides Oncosem components, such as pinch clamps, roller clamps, 3/4 way connectors, vial adapters, drip chambers, hydrophobic caps, male and rotating luer locks, spikes, taxol filters, check valves, and covers.
Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi Fundamentals Summary
| ONCSM fundamental statistics | |
|---|---|
| Market cap | ₺2.32b |
| Earnings (TTM) | -₺31.78m |
| Revenue (TTM) | ₺273.18m |
8.5x
P/S Ratio-72.9x
P/E RatioIs ONCSM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ONCSM income statement (TTM) | |
|---|---|
| Revenue | ₺273.18m |
| Cost of Revenue | ₺179.18m |
| Gross Profit | ₺94.00m |
| Other Expenses | ₺125.78m |
| Earnings | -₺31.78m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.33 |
| Gross Margin | 34.41% |
| Net Profit Margin | -11.63% |
| Debt/Equity Ratio | 23.7% |
How did ONCSM perform over the long term?
See historical performance and comparison